Welcome to our ’ATMP world tour’ program for 2023!
The event is being held virtually June 28-30, 2023. The full program can be found further down.
We’re very pleased to bring you a star studded cast of ’world leading’ ATMP activities discussing the competencies, partnerships and infrastructures that make great ideas and great technologies a reality for patients.
This event has been tailored to the online world and will be streamed live on this website. All presentations will be recorded for viewing within 2 months of the publication.
To suit the online format, for every hour timeslot eg. 13:00 you will get;
- 4min before the hour (eg. 12:56), your tour of the world, a slide with 3 things the speaker loves about the city they live in accompanied by our ’time to connect’ sponsorship slideshow
- 2min over the hour (eg. 13:02) the host welcomes participants, introduces themselves, the topic and the speaker
- 5min over the hour (eg. 13:05) speaker presentation begins
- 30min over the hour (eg. 13:30) question/discussion time lead by host, audience participation
- 56min over the hour (eg. 13:56) session ends
To view, right click and open in a new tab. The graphic gives the Swedish/CEST time of the presentation in blue and the ’local’ time of the presenter in green. The dates are Tuesday June 28th till Friday June 30th, 2023.
Wednesday June 28th 9:00-13:00 CEST
9:00 – ”Delivering ATMP Clinical Trials a Public Hospital”
Speaker: Sharon Sagnella, Department of Cell & Molecular Therapies, Royal Prince Alfred Hospital, Sydney, Australia.
Host: Gisela Helenius, ATMP Center, Skåne University Hospital.
10:00 – ”Clinical trials nurse functions”
Speaker: Aimei Lee, Royal Prince Alfred Hospital, Sydney, Australia.
Host: Jenny Gustafsson, Drottning Silvias Barnsjukhus, Gothenburg, Sweden.
11:00 – “Regulatory harmonization in Asia Pacific : APACRM”
Speaker: Setsuko Hashimoto, FIRM and CellSeed Inc., Tokyo, Japan.
Host: Axel Ståhlbom, Biological Regulatory Advice AB, Uppsala, Sweden.
12:00 – ”Novel AAV development”
Speaker: Leszek Lisowski, Children’s Medical Research Institute, The University of Sydney, Australia.
Host: Johan Rockberg, KTH Royal Institute of Technology, Stockholm, Sweden.
Thursday June 29th 13:00-17:00 CEST
13:00 – ”Transforming patient care – pushing the boundaries within ATMP”
Speaker: Steffen Thirstrup, MD, PhD. Chief Medical Officer at The European Medicines Agency. Affiliated Professor, Copenhagen Centre for Regulatory Science (CORS), Amsterdam, The Netherlands.
Host: Peter Hovstadius, MD, PhD. Chief Medical Officer at XNK Therapeutics, Stockholm, Sweden.
14:00 – ”Highlights and hurdles in development of gene therapies for genetic disease”
Speaker: Katherine High, Rockefeller University, Haverford, USA.
Host: Jan Nilsson, CEO CombiGene, Lund, Sweden.
15:00 – ”Quality Challenges for ATMPs – Managing a Complex Global QC Testing Network for Autologous Cell Therapies and Manufacturing/Testing Capacity Extensions”
Speaker: Stephan Krause, Executive Director, Global Cell Therapy Quality, BMS. Chair, PDA ATMP Advisory Board, Gaithersburg, USA.
Host: Paula Salminkangas, Director of Biopharmaceuticals and ATMPs, NDA Advisory Board, Helsinki, Finland.
16:00 – ”Linking healthcare and company data – Tamro LINK”
Speaker: Essi Kariaho, Pharmaca Health Intelligence, Finland
Host: Pekka Ihalmo, Market Access & Government Affairs Lead Finland at Janssen EMEA
Friday June 30th 8:00-12:00 CEST
8:00 – ”Implementing ATMPs in public healthcare system – Australian Experience”
Speaker: Filimon Haile, Program Manager, Highly Specialised Therapies, Victorian Department of Health, Australia
Host: Gustaf Befrits, Health Economic adviser with the NT-council, Sweden.
9:00 – “Opportunities & Developments in Adherent Stem Cells Manufacturing”
Speaker: Steve Oh, Ph.D. Independent Cell Therapy Leader, Singapore.
Host: Ricardo Baptista, CTO Alder Therapeutics, Sweden.
10:00 – ”Industrially Scalable Cell Manufacturing Using Extrusion CellFiber”
Speaker: Kaz Furuishi, Chief Strategy Officer, Cell Fiber, Tokyo, Japan.
Host: Kristina Runeberg, Takara Bio Europe, Gothenburg, Sweden.
11:00 – ”Early access in France, a unique framework to accelerate patient access to innovative therapies”
Speaker: Véronique Hédo, New Products Access Lead & Early Access PMO Janssen, France.
Host: Fredrik Gerstoft, Market Access Lead Denmark, Janssen.